These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 31871303)

  • 21. Agonists and antagonists bind to an A-A interface in the heteromeric 5-HT3AB receptor.
    Lochner M; Lummis SC
    Biophys J; 2010 Apr; 98(8):1494-502. PubMed ID: 20409468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of ginsenoside interaction sites in 5-HT3A receptors.
    Lee BH; Lee JH; Lee SM; Jeong SM; Yoon IS; Lee JH; Choi SH; Pyo MK; Rhim H; Kim HC; Jang CG; Lee BC; Park CS; Nah SY
    Neuropharmacology; 2007 Mar; 52(4):1139-50. PubMed ID: 17257631
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A triad of residues is functionally transferrable between 5-HT
    Mosesso R; Dougherty DA
    J Biol Chem; 2018 Feb; 293(8):2903-2914. PubMed ID: 29298898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The nonpsychoactive cannabinoid cannabidiol inhibits 5-hydroxytryptamine3A receptor-mediated currents in Xenopus laevis oocytes.
    Yang KH; Galadari S; Isaev D; Petroianu G; Shippenberg TS; Oz M
    J Pharmacol Exp Ther; 2010 May; 333(2):547-54. PubMed ID: 20160007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression of the 5-HT3B serotonin receptor subunit alters the biophysics of the 5-HT3 receptor.
    Hapfelmeier G; Tredt C; Haseneder R; Zieglgänsberger W; Eisensamer B; Rupprecht R; Rammes G
    Biophys J; 2003 Mar; 84(3):1720-33. PubMed ID: 12609874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The muscarinic antagonists scopolamine and atropine are competitive antagonists at 5-HT3 receptors.
    Lochner M; Thompson AJ
    Neuropharmacology; 2016 Sep; 108():220-8. PubMed ID: 27108935
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A bupropion modulatory site in the Gloeobacter violaceus ligand-gated ion channel.
    Do HQ; Pirayesh E; Ferreira G; Pandhare A; Gallardo ZR; Jansen M
    Biophys J; 2024 Jul; 123(14):2185-2198. PubMed ID: 38678367
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of Δ9-tetrahydrocannabinol on 5-HT3 receptors depends on the current density.
    Yang KH; Isaev D; Morales M; Petroianu G; Galadari S; Oz M
    Neuroscience; 2010 Nov; 171(1):40-9. PubMed ID: 20800662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activation of human 5-hydroxytryptamine type 3 receptors via an allosteric transmembrane site.
    Lansdell SJ; Sathyaprakash C; Doward A; Millar NS
    Mol Pharmacol; 2015 Jan; 87(1):87-95. PubMed ID: 25338672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subtle Differences among 5-HT
    Price KL; Hirayama Y; Lummis SCR
    ACS Chem Neurosci; 2017 May; 8(5):1085-1091. PubMed ID: 28367632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The multimodal antidepressant vortioxetine may facilitate pyramidal cell firing by inhibition of 5-HT
    Dale E; Grunnet M; Pehrson AL; Frederiksen K; Larsen PH; Nielsen J; Stensbøl TB; Ebert B; Yin H; Lu D; Liu H; Jensen TN; Yang CR; Sanchez C
    Brain Res; 2018 Jun; 1689():1-11. PubMed ID: 29274875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The 5-HT3B subunit confers reduced sensitivity to picrotoxin when co-expressed with the 5-HT3A receptor.
    Das P; Dillon GH
    Brain Res Mol Brain Res; 2003 Nov; 119(2):207-12. PubMed ID: 14625088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Direct activation by dopamine of recombinant human 5-HT1A receptors: comparison with human 5-HT2C and 5-HT3 receptors.
    Oz M; Zhang L; Rotondo A; Sun H; Morales M
    Synapse; 2003 Dec; 50(4):303-13. PubMed ID: 14556235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endogenous cannabinoid, anandamide, acts as a noncompetitive inhibitor on 5-HT3 receptor-mediated responses in Xenopus oocytes.
    Oz M; Zhang L; Morales M
    Synapse; 2002 Dec; 46(3):150-6. PubMed ID: 12325042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antiemetics of the 5-hydroxytryptamine 3A antagonist class inhibit muscle nicotinic acetylcholine receptors.
    Paul M; Callahan R; Au J; Kindler CH; Yost CS
    Anesth Analg; 2005 Sep; 101(3):715-721. PubMed ID: 16115980
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A role for the Val291 residue within the transmembrane domain 2 in diltiazem- and TMB-8 [3,4,5-trimethoxybenzoic acid 8-(diethylamino)octyl ester]-mediated 5-hydroxytryptamine type 3A receptor regulations.
    Lee BH; Choi SH; Pyo MK; Shin TJ; Hwang SH; Kim BR; Lee JH; Rhim H; Kim HC; Nah SY
    Biol Pharm Bull; 2009 May; 32(5):861-7. PubMed ID: 19420755
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resveratrol enhances 5-hydroxytryptamine type 3A receptor-mediated ion currents: the role of arginine 222 residue in pre-transmembrane domain I.
    Lee BH; Hwang SH; Choi SH; Shin TJ; Kang J; Lee SM; Nah SY
    Biol Pharm Bull; 2011; 34(4):523-7. PubMed ID: 21467640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interactions of metoclopramide and ergotamine with human 5-HT(3A) receptors and human 5-HT reuptake carriers.
    Walkembach J; Brüss M; Urban BW; Barann M
    Br J Pharmacol; 2005 Oct; 146(4):543-52. PubMed ID: 16041395
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nondepolarizing neuromuscular blockers inhibit the serotonin-type 3A receptor expressed in Xenopus oocytes.
    Min KT; Wu CL; Yang J
    Anesth Analg; 2000 Feb; 90(2):476-81. PubMed ID: 10648343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5-HT3 Receptor Brain-Type B-Subunits are Differentially Expressed in Heterologous Systems.
    Corradi J; Thompson AJ; McGonigle I; Price KL; Bouzat C; Lummis SC
    ACS Chem Neurosci; 2015 Jul; 6(7):1158-64. PubMed ID: 25951416
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.